Bicocca Open Archive

Logo unimib boa

Romano, M., Galli, A., Panini, N., Paracchini, L., Beltrame, L., Bello, E., et al. (2014). Trabectedin and lurbinectedin are effective against leukemic cells derived from patients affected by chronic and juvenile myelomonocytic leukemia. In 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (pp.21-21). ELSEVIER SCI LTD [10.1016/S0959-8049(14)70174-1].

Trabectedin and lurbinectedin are effective against leukemic cells derived from patients affected by chronic and juvenile myelomonocytic leukemia

Zambelli A;
2014
abstract
Oncology
English
26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - NOV 18-21, 2014
2014
26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
2014
50
S6
21
21
48
none
Romano, M., Galli, A., Panini, N., Paracchini, L., Beltrame, L., Bello, E., et al. (2014). Trabectedin and lurbinectedin are effective against leukemic cells derived from patients affected by chronic and juvenile myelomonocytic leukemia. In 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (pp.21-21). ELSEVIER SCI LTD [10.1016/S0959-8049(14)70174-1].
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/560701
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact